Search Tag: cost analysis

Executive Health Management

2016 29 Apr

Approximately 80 percent of admissions, deaths, complications, and inpatient costs related to operative emergency general surgery nationwide can be traced to only seven procedures, according to a study published online by JAMA Surgery . These include colectomy, small-bowel resection, cholecystectomy, operative management of peptic ulcer disease, removal...Read more

IT Management

2016 19 Jan

The University of Pittsburgh Medical Center (UPMC) has formed a strategic partnership with Health Catalyst to develop and commercialise a hospital-based costing analysis solution. The two organisations will combine expertise and technologies to help health systems solve one of their most pressing problems — how to measure the true cost of healthcare...Read more

ICU Management

2016 06 Jan

Single-patient rooms in the ICU may be more costly to build and operate, but the resultant cost savings from reductions in nosocomial infections outweigh the additional construction and operating expenses, according to a new study published in Journal of Critical Care . Despite recent efforts to improve healthcare quality and safety, there is still...Read more

Executive Health Management

2015 17 Jul

Amidst changing trends in patient care delivery, it behooves healthcare providers to improve quality while also containing costs. A hospital's workforce is a key consideration in quality and cost analysis, so it's essential to have the proper mix of core and contingent staffing for more efficient work flow. Nurses and other healthcare professionals...Read more

ICU Management

2014 08 Oct

How much does it actually cost to treat sepsis in the ICU? Almost €30,000 according to a study presented at the European Society of Intensive Care Medicine (ESICM) congress in Barcelona last week by Marlies Koster-Brouwer, from the University Medical Center Utrecht in the Netherlands. Koster-Brouwer observed that few studies have specifically investigated...Read more

Cardiology Management

2014 12 Sep

Researchers from the University of Washington in Seattle (USA) reviewed the cost-effectiveness of using recombinant tissue-type plasminogen activator (r-tPA) to treat stroke. Their findings show that on average, each patient treated with r-tPA gained 0.39 quality-adjusted life years (QALYs) translating to a lifetime cost savings of about $25,000 compared...Read more